HIGHLIGHTS
- who: -aminogeldanamycin and colleagues from the Department of Molecular Biology of Cancer, Medical University of Lodz, Lodz, Poland have published the Article: Molecular Sciences, in the Journal: (JOURNAL)
- what: The authors investigate the effect of a potent inhibitor on factor-kappa B (NF-κB) activity in BRAFV600E and NRASQ61R patient-derived melanoma cell lines. The authors focused on molecular events at time intervals, not exceeding this time point. The authors focused on a early stage of adaptation to treatment . In the of p65 atstudy, this residue promotes conformational switchand thatitsenables nuclear translocation NF-κB present . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.